Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia

Cancer

Volumn 88, Issue 8, 2000, Pages 1964-1969

  Hurwitz, Craig A ^a   Silverman, Lewis B ^b   Schorin, Marshall A ^c   Clavell, Luis A ^d   Dalton, Virginia K ^b   Glick, Kathleen M ^a   Gelber, Richard D ^e   Sallan, Stephen E ^b  

^a Maine Children's Cancer Program Scarborough   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c OCHSNER MEDICAL CENTER   (United States)

^d San Jorge Children's Hospital   (Puerto Rico)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Acute lymphoblastic leukemia; Dexamethasone; Pediatrics; Remission induction

Indexed keywords

ASPARAGINASE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER REGRESSION; CANCER RISK; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; IMMUNOPHENOTYPING; INCIDENCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUBSTITUTION THERAPY;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; FATAL OUTCOME; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; METHYLPREDNISOLONE; PREDNISONE; SEPSIS;

EID: 0034655211     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000415)88:8<1964::AID-CNCR27>3.0.CO;2-1     Document Type: Article

References (29)

1. Pearson OH, Eliel LP. Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias. JAMA 1950;144:1349-53.
2. Hyman CB, Borda EC, Brubaker C, Hammond D, Sturgeon P. Prednisone in childhood leukemia: comparison of interrupted with continuous therapy. Pediatrics 1959;24:1005-8.
3. Hyman CB, Sturgeon P. Prednisone therapy of acute lymphatic leukemia in children. Cancer 1956;9:965-70.
4. Gaynon PS, Lustig RH. The use of glucocorticoids in acute lymphoblastic leukemia of childhood: molecular, cellular, and clinical considerations. J Pediatr Hematol Oncol 1995; 17:1-12.
5. Quddus FF, Levanthal BG, Boyett JM, Pullen DJ, Crist WM, Borowitz MJ. Glucocorticoid receptors in immunological subtypes of childhood acute lymphocytic leukemia cells: a Pediatric Oncology Group study. Cancer Res 1985;45:6482-6.
6. Munck A, Guyre PM, Holbrook NJ. Physiological function of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984;5:25-44.
7. Arya SK, Wong-Staal F, Gallo RC. Dexamethasone-mediated inhibition of human T-cell growth factor and γ-interferon messenger RNA. J Immunol 1984;133:273-6.
8. Schuchard M, Landers JP, Sandhu NP, Spelsberg TC. Steroid hormone regulation of nuclear proto-oncogenes. Endocr Rev 1993;14:659-69.
9. Harmon JM, Norman MR, Fowlkes BJ, Thompson EB. Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line. J Cell Physiol 1979;98:267-78.
10. Baxter GD, Collins RJ, Harmon BV, Kumar S, Prentice RL, Smith PJ, et al. Cell death by apoptosis in acute leukemia. J Pathol 1989;158:123-9.
11. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
12. Inati A, Sallan SE, Cassady JR, Hitchcock-Bryan S, Clavell LA, Belli JA, et al. Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate. Blood 1983;61:297-303.
13. Robison LL, Nesbit ME, Sather HN, Meadows AT, Ortega JA, Hammond GD. Factors associated with IQ scores in long-term survivors of childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 1984;6:115-22.
14. Waber DP, Tarbell NJ, Kahn CM, Gelber RD, Sallan SE. The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. J Clin Oncol 1992;10:810-7.
15. Ochs J, Mulhern R, Fairclough D, Parvey L, Whitaker J, Ch'ien L, et al. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. J Clin Oncol 1991; 9:145-51.
16. Veerman AJP, Hahlen K, Kamps WA, Van Leeuwen EF, De Vaan GA, Solbu G, et al. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996;14:911-8.
17. Balis FM, Lester CM, Chrousos GP, Heideman RL, Poplack DG. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol 1987;5:202-7.
18. Jones B, Freeman Al, Shuster JJ, Jacquillat C, Weil M, Pochedly C, et al. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol 1991;19:269-75.
19. Silverman LB, Gelber RD, Kimball-Dalton V, Young ML, Sallon SE. Results of the Dana-Farber Cancer Institute (DFCI) consortium protocol 91-01 for children with acute lymphoblastic leukemia (ALL). Blood 1998: 92:483a.
20. Donner A, Li KY. The relationship between chi-square statistics from matched and unmatched analyses. J Clin Epidemiol 1990;43:827-31.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
22. Bostrom B, Gaynon PS, Sather H, Gold S, Hutchinson RI, Provisor A, et al. Dexamethasone (Dex) decreases central nervous system (CNS) relapse and improves event-free survival in lower risk acute lymphoblastic leukemia. Proc Am Soc Clin Oncol 1998;17:527a.
23. Vietti TJ, Starling K, Wilbur JR, Lonsdale D, Lane DM. Vincristine, prednisone, and daunomycin in acute leukemia of childhood. Cancer 1971;27:602-7.
24. Sallan SE, Cammita BM, Cassady JR, Nathan DG, Frei E. Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results. Blood 1978;51:425-33.
25. Aur RJ, Simone JV, Verzosa MS, Hustu HO, Barker LF, Pinkel DP, et al. Childhood acute lymphocytic leukemia: Study VIII. Cancer 1978;42:2123-34.
26. Pinkel D. Treatment of acute leukemia. Pediatr Clin North Am 1976;23:117-30.
27. Nakamura S, Gelber RD, Blattner S, Sallan SE, Chanock SJ. Long-term follow-up and infectious complications of therapy for acute lymphoblastic leukemia in children. Int J Pediatr Hematol Oncol 2000;6:321-30.
28. Nesbit M, Chard R, Evans A, Karon M, Hammond GD. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia. Am J Pediatr Hematol Oncol 1979;1:9-13.
29. Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V, et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital acute lymphoblastic leukemia consortium protocol 85-01. J Clin Oncol 1994;12:740-7.